Non-High-Density Lipoprotein Cholesterol and Risk of Stroke Subtypes and Coronary Heart Disease: The Japan Public Health Center-Based Prospective (JPHC) Study-Reference-Cited by-同舟云学术

Non-High-Density Lipoprotein Cholesterol and Risk of Stroke Subtypes and Coronary Heart Disease: The Japan Public Health Center-Based Prospective (JPHC) Study

Published:2020-04-01 Issue:4 Volume:27 Page:363-374
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Saito Isao¹,Yamagishi Kazumasa²,Kokubo Yoshihiro³,Yatsuya Hiroshi⁴,Iso Hiroyasu⁵,Sawada Norie⁶,Inoue Manami⁶,Tsugane Shoichiro⁶

Affiliation:

1. Department of Public Health and Epidemiology, Faculty of Medicine, Oita University

2. Department of Public Health Medicine, Faculty of Medicine, University of Tsukuba

3. Department of Preventive Cardiology, National Cerebral and Cardiovascular Center

4. Department of Public Health, Fujita Health University

5. Public Health, Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University

6. Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/27/4/27_50385/_pdf

Reference38 articles.

1. 1) The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA, 2009; 302: 1993-2000

2. 2) Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y, Group MS. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA study): A prospective randomised controlled trial. Lancet, 2006; 368: 1155-1163

3. 3) Cholesterol Treatment Trialists C, Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, Simes J, Collins R, Kirby A, Colhoun H, Braunwald E, La Rosa J, Pedersen TR, Tonkin A, Davis B, Sleight P, Franzosi MG, Baigent C, Keech A. Efficacy and safety of ldl-lowering therapy among men and women: Meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet, 2015; 385: 1397-1405

4. 4) Imamura T, Doi Y, Ninomiya T, Hata J, Nagata M, Ikeda F, Mukai N, Hirakawa Y, Yoshida D, Fukuhara M, Kitazono T, Kiyohara Y. Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: The Hisayama study. Atherosclerosis, 2014; 233: 343-348

5. 5) Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Yoshimasa Y, Okayama A. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis, 2009; 203: 587-592

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Phytochemicals in The Management of Lifestyle Disorders;African Journal of Environment and Natural Science Research;2024-08-06

2. Sex differences in risk factor relationships with subarachnoid haemorrhage and intracranial aneurysms: A Mendelian randomization study;European Stroke Journal;2024-07-30

3. Predictive Value of Non-High-Density to High-Density Lipoprotein Ratio for Coronary Heart Disease and Mortality in Adults;2024-06-07

4. JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease;Circulation Journal;2024-04-25

5. Unveiling Coronary Heart Disease Prediction through Machine Learning Techniques: Insights from the Suita Population-Based Cohort Study;2024-04-02